Literature DB >> 32205336

Are my patients with rheumatic diseases at higher risk of COVID-19?

Gabriel Figueroa-Parra1, Gloria Mayela Aguirre-Garcia2, Carmen Magdalena Gamboa-Alonso1, Adrian Camacho-Ortiz2, Dionicio Angel Galarza-Delgado3.   

Abstract

Entities:  

Keywords:  DMARDs (biologic); DMARDs (synthetic); autoimmune diseases; epidemiology; infections

Mesh：

Substances：

Year:  2020        PMID： 32205336     DOI： 10.1136/annrheumdis-2020-217322

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  28 in total

Review 1.  Thyroid disease in the time of COVID-19.

Authors:  Dorota Dworakowska; Ashley B Grossman
Journal:  Endocrine       Date:  2020-06-07       Impact factor: 3.633

2.  Coronavirus disease 2019 (COVID-19) in autoimmune and inflammatory conditions: clinical characteristics of poor outcomes.

Authors:  Fernando Montero; Julia Martínez-Barrio; Belén Serrano-Benavente; Teresa González; Javier Rivera; Juan Molina Collada; Isabel Castrejón; Jose Álvaro-Gracia
Journal:  Rheumatol Int       Date:  2020-08-13       Impact factor: 2.631

3.  Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic.

Authors:  Clovis Artur Silva; Lígia Bruni Queiroz; Claudia de Brito Fonseca; Luís Eduardo Vargas da Silva; Benito Lourenço; Heloisa Helena Sousa Marques
Journal:  Clinics (Sao Paulo)       Date:  2020-05-08       Impact factor: 2.365

4.  Risk of COVID-19 infection in patients with rheumatic disease taking disease-modifying anti-rheumatic drugs.

Authors:  Behnaz Yousefghahari; Sanaz Navari; Mahmoud Sadeghi; Shima Soleimaniamiri; Mohammadjafar Soleimaniamiri; Behzad Heidari; Mansour Babaei; Kian Ghodrati; Ardeshir Guran; Hemmat Gholinia
Journal:  Clin Rheumatol       Date:  2021-05-29       Impact factor: 2.980

5.  COVID-19 in patients with rheumatic disease in Hubei province, China: a multicentre retrospective observational study.

Authors:  Jixin Zhong; Guifen Shen; Huiqin Yang; Anbin Huang; Xiaoqi Chen; Li Dong; Bin Wu; Anbin Zhang; Linchong Su; Xiaoqiang Hou; Shulin Song; Huiling Li; Wenyu Zhou; Tao Zhou; Qin Huang; Aichun Chu; Zachary Braunstein; Xiaoquan Rao; Cong Ye; Lingli Dong
Journal:  Lancet Rheumatol       Date:  2020-07-03

Review 6.  How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion.

Authors:  Piercarlo Sarzi-Puttini; Daniela Marotto; Marco Antivalle; Fausto Salaffi; Fabiola Atzeni; Giovanni Maconi; Giovanni Monteleone; Giuliano Rizzardini; Spinello Antinori; Massimo Galli; Sandro Ardizzone
Journal:  Autoimmun Rev       Date:  2020-05-05       Impact factor: 9.754

Review 7.  COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.

Authors:  A M Isidori; G Arnaldi; M Boscaro; A Falorni; C Giordano; R Giordano; R Pivonello; R Pofi; V Hasenmajer; M A Venneri; E Sbardella; C Simeoli; C Scaroni; A Lenzi
Journal:  J Endocrinol Invest       Date:  2020-04-25       Impact factor: 4.256

Review 8.  SARS-CoV-2 infection among patients with systemic autoimmune diseases.

Authors:  Giacomo Emmi; Alessandra Bettiol; Irene Mattioli; Elena Silvestri; Gerardo Di Scala; Maria Letizia Urban; Augusto Vaglio; Domenico Prisco
Journal:  Autoimmun Rev       Date:  2020-05-05       Impact factor: 9.754

9.  Contributions of Latin American researchers in the understanding of the novel coronavirus outbreak: a literature review.

Authors:  Karen Y Fiesco-Sepúlveda; Luis Miguel Serrano-Bermúdez
Journal:  PeerJ       Date:  2020-06-04       Impact factor: 2.984

Review 10.  Mental Health and Psychological Wellbeing in Rheumatoid Arthritis during COVID-19 - Can Physical Activity Help?

Authors:  Jet J C S Veldhuijzen van Zanten; Sally A M Fenton; Sophia Brady; George S Metsios; Joan L Duda; George D Kitas
Journal:  Mediterr J Rheumatol       Date:  2020-09-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.